相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy
James Ying et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells
Changsen Leng et al.
ONCOLOGY REPORTS (2016)
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis
Francesco Massari et al.
TARGETED ONCOLOGY (2016)
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients
Pierpaolo Correale et al.
ONCOIMMUNOLOGY (2016)
Emerging Targets for Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach?
Maria Raffaella Ambrosio et al.
CURRENT DRUG TARGETS (2016)
Biomarkers for immunotherapy in genitourinary malignancies
Susan F. Slovin
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Predictive Value of the Platelet-To-Lymphocyte Ratio in Diagnosis of Prostate Cancer
Ozgur Haki Yuksel et al.
Asian Pacific Journal of Cancer Prevention (2015)
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
M. J. McCoy et al.
BRITISH JOURNAL OF CANCER (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Vitamin D, Inflammation, and Colorectal Cancer Progression: A Review of Mechanistic Studies and Future Directions for Epidemiological Studies
A. Suzanne van Harten-Gerritsen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients
Maria Grazia Cusi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Radiation therapy and immunomodulation: Focus on experimental data
E. Deutsch et al.
CANCER RADIOTHERAPIE (2015)
A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
Edgardo D. Carosella et al.
EUROPEAN UROLOGY (2015)
Radio-immunotherapy: the focused beam expands
Benjamin Frey et al.
LANCET ONCOLOGY (2015)
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
Andrew B. Sharabi et al.
LANCET ONCOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
Ninh M. La-Beck et al.
PHARMACOTHERAPY (2015)
Immunologic Checkpoints Blockade in Renal Cell, Prostate, and Urothelial Malignancies
Sergio Bracarda et al.
SEMINARS IN ONCOLOGY (2015)
Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells
Zhe Yu et al.
ONCOTARGET (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis
Silvio Daester et al.
ONCOIMMUNOLOGY (2015)
Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): At the cross-road of pancreatic cancer cell proliferation
Alessandra Dicitore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue
Frank Christian Schultze et al.
CLINICAL BIOCHEMISTRY (2014)
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96-02/AUO AP 09/95 Trial
Thomas Wiegel et al.
EUROPEAN UROLOGY (2014)
Gemcitabine, Oxaliplatin, Levofolinate, 5-Fluorouracil, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-2 (GOLFIG) Versus FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients: The GOLFIG-2 Multicentric Open-label Randomized Phase III Trial
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Tumor infiltrating B-cells are increased in prostate cancer tissue
Jason R. Woo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Infiltration of CD8+Lymphocytes is an Independent Prognostic Factor of Biochemical Failure-Free Survival in Prostate Cancer
Nora Ness et al.
PROSTATE (2014)
FOXP3 Transcription Factor: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast Cancer
Leandra Fiori Lopes et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Prostate Cancer Immunotherapy: Beyond Immunity to Curability
Jonathan W. Simons
CANCER IMMUNOLOGY RESEARCH (2014)
Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities
Cirino Botta et al.
FRONTIERS IN ONCOLOGY (2014)
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system
Phillip M. Pierorazio et al.
BJU INTERNATIONAL (2013)
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta et al.
CANCER BIOLOGY & THERAPY (2013)
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
Jingying Xu et al.
CANCER RESEARCH (2013)
Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies
Giovanni Vitale et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
S. Ladoire et al.
ANNALS OF ONCOLOGY (2012)
Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma
Pierpaolo Correale et al.
CLINICAL CANCER RESEARCH (2012)
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro
P. Correale et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients
Cirino Botta et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Tumor infiltration by chemokine receptor 7 (CCR7)+ T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
Pierpaolo Correale et al.
ONCOIMMUNOLOGY (2012)
Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
Martin Poelcher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2010)
CCR7 regulates lymphocyte egress and recirculation through body cavities
Uta E. Hoepken et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells
Giovanni Vitale et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Molecular orchestration of differentiation and function of regulatory T cells
Li-Fan Lu et al.
GENES & DEVELOPMENT (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial)
Pierpaolo Correale et al.
CLINICAL CANCER RESEARCH (2008)
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade
Hiroyoshi Suzuki et al.
JOURNAL OF UROLOGY (2008)
Radiotherapy augments the immune response to prostate cancer in a time-dependent manner
Timothy J. Harris et al.
PROSTATE (2008)
Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group
Philip Poortmans et al.
RADIOTHERAPY AND ONCOLOGY (2007)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues
LA Ebert et al.
MOLECULAR IMMUNOLOGY (2005)
Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors
TRDJ Radstake et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy
S Kojima et al.
JOURNAL OF UROLOGY (2004)
分享论文
